<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>6885</number>
    <updateDate>2023-01-11T13:42:54Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:42:54Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2020-05-15</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 166, Number 92 (Friday, May 15, 2020)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. FLORES:H.R. 6885.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 1. . . to lay and collect taxes, duties, imposts andexcises, to pay the debts and provide for the common defenseand general welfare of the United States; but all duties,imposts and excises shall be uniform throughout the UnitedStates;Article 1, Section 8, Clause 3To regulate commerce with foreign nations, and among theseveral states, and with the Indian tribes;[Page H2261]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2020-05-15T13:01:40Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2020-05-15T13:01:35Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2020-05-15</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-05-15</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-05-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-05-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>F000461</bioguideId>
        <fullName>Rep. Flores, Bill [R-TX-17]</fullName>
        <firstName>Bill</firstName>
        <lastName>Flores</lastName>
        <party>R</party>
        <state>TX</state>
        <district>17</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>W000827</bioguideId>
        <fullName>Rep. Wright, Ron [R-TX-6]</fullName>
        <firstName>Ron</firstName>
        <lastName>Wright</lastName>
        <party>R</party>
        <state>TX</state>
        <district>6</district>
        <sponsorshipDate>2020-06-18</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001307</bioguideId>
        <fullName>Rep. Baird, James R. [R-IN-4]</fullName>
        <firstName>James</firstName>
        <lastName>Baird</lastName>
        <party>R</party>
        <state>IN</state>
        <middleName>R.</middleName>
        <district>4</district>
        <sponsorshipDate>2020-07-01</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000165</bioguideId>
        <fullName>Rep. Tiffany, Thomas P. [R-WI-7]</fullName>
        <firstName>Thomas</firstName>
        <lastName>Tiffany</lastName>
        <party>R</party>
        <state>WI</state>
        <middleName>P.</middleName>
        <district>7</district>
        <sponsorshipDate>2020-07-01</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Asia</name>
        </item>
        <item>
          <name>China</name>
        </item>
        <item>
          <name>Civil actions and liability</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Employment and training programs</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Government trust funds</name>
        </item>
        <item>
          <name>Health information and medical records</name>
        </item>
        <item>
          <name>India</name>
        </item>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>Tariffs</name>
        </item>
        <item>
          <name>Trade restrictions</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2020-05-15</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2021-01-28T15:13:32Z</updateDate>
        <text><![CDATA[ <p><b>Safe and Secure Medicine Supply for Hardworking Americans Act of 2020</b></p> <p>This bill bans in certain instances the importation of drugs and medical devices from a foreign manufacturing facility that has been subject to a recall, imposes additional duties on imported drugs, and contains other related provisions.</p> <p>The Food and Drug Administration shall ban drug or device imports from a foreign facility for a specified amount of time if a drug or device from that facility has been subject to a Class I or Class II recall. The bill imposes civil monetary fines for any individual or entity that violates such an import ban.</p> <p>The bill also imposes, on top of any other duties, a 25% duty on drugs imported from China, a 20% duty on drugs imported from India, and a 10% duty on drugs imported from any other country. </p> <p>The duties and fines established under this bill shall go into a fund for supporting and incentivizing new pharmaceutical or medical device manufacturing in the United States. </p> <p>The bill also requires each drug sold to state on its label the country of origin of each active pharmaceutical ingredient.</p>]]></text>
      </summary>
    </summaries>
    <title>Safe and Secure Medicine Supply for Hardworking Americans Act of 2020</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Safe and Secure Medicine Supply for Hardworking Americans Act of 2020</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to prohibit the importation of a drug or device that was manufactured at a banned foreign facility, to create incentives for pharmaceutical or device companies to increase manufacturing capacity in the United States, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Safe and Secure Medicine Supply for Hardworking Americans Act of 2020</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2020-05-15T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr6885ih/xml/BILLS-116hr6885ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-05-15</actionDate>
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
